免疫微环境对食道腺癌预后的影响
Dimitra V Peristeri1, Munir Tarazi2, Patrick Casey1
1Department of Upper GI Surgery, Salford Royal Hospital, Stott Lane, Salford, UK.
Best practice & research. Clinical gastroenterology
|December 7, 2024
概括
消化管腺癌 (OAC) 是一种致命的癌症. 了解瘤微环境 (TME) 和免疫细胞对于开发有效的免疫疗法以改善患者生存至关重要.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症研究 癌症研究
背景情况:
- 消化管腺癌 (OAC) 由于治疗反应不佳和生存率低,导致全球显著的死亡率.
- 瘤微环境 (TME) 和患者的免疫特征在指导治疗决策方面越来越重要.
- 虽然炎症性TME与更好的结果相关,但OAC通常表现出免疫抑制和耐治疗的TME.
研究的目的:
- 审查OAC中TME和免疫检查点抑制剂的现有证据.
- 探索针对OAC的最近和正在进行的治疗策略.
- 突出需要更深入地了解OAC的免疫微环境,以实现个性化治疗.
主要方法:
- 对OAC,TME和免疫治疗研究的文献综述.
- 对OAC中免疫检查点抑制剂的累积证据的分析.
- 讨论当前和新兴的治疗干预措施.
主要成果:
- 免疫丰富的TME患者通常在OAC中经历更好的生存结果.
- OAC TME主要是免疫抑制的,有助于治疗耐药性.
- 免疫检查点抑制剂正在被纳入OAC治疗计划.
结论:
- 通过了解TME交叉通话来利用患者的免疫系统是改善OAC生存的关键.
- 为了有效的免疫治疗,需要对OAC免疫微环境进行进一步的研究.
- 针对TME相互作用的个性化治疗方法对OAC治疗充满希望.
更多相关视频
07:44Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
7.5K
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
1.2K
相关概念视频
02:17The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
01:27Tumor Immunotherapy
476
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
476